← Back to Search

Procedure

Refractive Error for Refractive Errors

N/A
Waitlist Available
Research Sponsored by Abbott Medical Optics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

The results of this trial will demonstrate that AVSS software performs as intended and is acceptable in a clinical setting.

Eligible Conditions
  • Refractive Errors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Other study objectives
Loss of More Than 2 Lines Best Spectacle Corrected Visual Acuity (BSCVA)
Percent Manifest Refraction Spherical Equivalent Within 1.0D

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Refractive ErrorExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
STAR S4IR LASIK with VSS-R ablation profile
2010
N/A
~150

Find a Location

Who is running the clinical trial?

Abbott Medical OpticsLead Sponsor
44 Previous Clinical Trials
6,643 Total Patients Enrolled
4 Trials studying Refractive Errors
581 Patients Enrolled for Refractive Errors
Nicholas Tarantino, ODStudy DirectorAbbott Medical Optics
7 Previous Clinical Trials
668 Total Patients Enrolled
2 Trials studying Refractive Errors
244 Patients Enrolled for Refractive Errors
~10 spots leftby Nov 2025